Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome, April 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 79 articles:
HTML format


 

Single Articles

  1. RUBERTO S, Santovito A, Caviglia GP, Noli M, et al
    Mycobacterium avium Subsp. paratuberculosis and Human Endogenous Retrovirus in Italian Patients With Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Immunology. 2025 Apr 4. doi: 10.1111/imm.13923.
    PubMed    
    Abstract available

  2. ALMADI MK, Sabr MS, Kofi M, Alaboodi T, et al
    Epidemiology and Risk Factors of Irritable Bowel Syndrome in the Saudi Population: A Systematic Review.
    Cureus. 2025;17:e79974.
    PubMed    
    Abstract available

  3. YU J, Li X, Sun Y, Wang L, et al
    Transcriptomic analysis and experiment to verify the mechanism of Xiaoyao San in the treatment of irritable bowel syndrome with depression.
    J Ethnopharmacol. 2025 Apr 1:119732. doi: 10.1016/j.jep.2025.119732.
    PubMed    
    Abstract available

  4. ADLER EC, Levine EH, Ibarra AN, Boparai ES, et al
    Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Neurogastroenterol Motil. 2025 Apr 3:e70037. doi: 10.1111/nmo.70037.
    PubMed    
    Abstract available

  5. JOHNSSON A, Ljotsson B, Liliequist BE, Skuladottir H, et al
    Cognitive behavioural therapy targeting cardiac anxiety post-myocardial infarction: results from two sequential pilot studies.
    Eur Heart J Open. 2025;5:oeaf020.
    PubMed    
    Abstract available

  6. MCNABOE RQ, Kong Y, Henderson WA, Cong X, et al
    Optimizing Sensor Locations for Electrodermal Activity Monitoring Using a Wearable Belt System.
    J Sens Actuator Netw. 2025;14:31.
    PubMed    
    Abstract available

  7. GERSON J
    Case Study: An Integrative Modification of Gut-Directed Hypnotherapy for a Patient with Intermittent Flares of Long-Standing Irritable Bowel Syndrome.
    Int J Clin Exp Hypn. 2025 Apr 1:1-6. doi: 10.1080/00207144.2025.2478858.
    PubMed    
    Abstract available

  8. KIM B, Wang Z, Meng X, Xie Z, et al
    An interorgan neuroimmune circuit promotes visceral hypersensitivity.
    Res Sq [Preprint]. 2025 Mar 17:rs.3.rs-6221928. doi: 10.21203/rs.3.rs-6221928.
    PubMed    
    Abstract available

  9. GERHOLD P, Lowe B, Huber S, Weigel A, et al
    [Podcasts for psychoeducation in irritable bowel syndrome: A mixed-methods analysis].
    Z Gastroenterol. 2025 Mar 31. doi: 10.1055/a-2550-9549.
    PubMed    
    Abstract available

  10. FAKHRI BAFGHI MS, Khoshnam Rad N, Roostaei G, Nikfar S, et al
    The reality of modeling irritable bowel syndrome: progress and challenges.
    Expert Opin Drug Discov. 2025;20:433-445.
    PubMed    
    Abstract available

  11. ISLAM JMA, Alam MJ, Karim MR, Ahmed F, et al
    Total and Segmental Colonic Transit Time in Patients with Constipation Attending in Dhaka Medical College Hospital: A Case Control Study.
    Mymensingh Med J. 2025;34:491-501.
    PubMed    
    Abstract available

  12. AL-MOHAISSEN MA, Al Zohaifi MA, Lee T, Almalki NA, et al
    Clinical Characterization of Blood Pressure Phenotypes: The BP Phenotype Score.
    Blood Press. 2025 Mar 30:1-22. doi: 10.1080/08037051.2025.2486284.
    PubMed    
    Abstract available

  13. PETTERSSON R, Strandh M, Lucas S
    Violence in adulthood amplifies the health correlates of childhood maltreatment.
    BMC Public Health. 2025;25:1193.
    PubMed    
    Abstract available

  14. GROEN SR, Keszthelyi D, Wilms E, Huig J, et al
    Colonic mucosal TRPA1 expression profiles in irritable bowel syndrome and its correlation to symptom severity: An exploratory study.
    Auton Neurosci. 2025;259:103273.
    PubMed    
    Abstract available

  15. HASEGAWA R, Nakaya K, Kanazawa M, Fukudo S, et al
    Corticotropin-releasing hormone receptor-1 antagonist attenuates visceral hypersensitivity induced by trinitrobenzene sulfonic acid colitis and maternal separation in rats.
    Biopsychosoc Med. 2025;19:5.
    PubMed    
    Abstract available

  16. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Irisin prevents visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Peptides. 2025;188:171394.
    PubMed    
    Abstract available

  17. CHU H, Zhong Y, Zhao J, Shan Y, et al
    Unravelling behavioural contributions to IBS risk: evidence from univariate and multivariate Mendelian randomisation.
    J Glob Health. 2025;15:04112.
    PubMed    
    Abstract available

  18. XUE F, Xue J, Zhao B, Zhu S, et al
    The Associations of Tobacco, Alcohol, and Coffee Consumption with Upper and Lower Gastrointestinal Disease Risk: A Mendelian Randomization Study.
    Gut Liver. 2025 Apr 11. doi: 10.5009/gnl240440.
    PubMed    
    Abstract available

  19. SANTUCCI NR, Waheed U, Li J, Mansi S, et al
    Auricular Allodynia is Associated With Worse Outcomes in Children With Functional Abdominal Pain Disorders Using Neurostimulation.
    Neuromodulation. 2025 Apr 10:S1094-7159(25)00129.
    PubMed    
    Abstract available

  20. JAFARI NASAB S, Feizi A, Hajihashemi P, Ani A, et al
    Dietary Quality Index-International and the odds of irritable bowel syndrome: a case-control study.
    Br J Nutr. 2025 Apr 10:1-26. doi: 10.1017/S0007114525000753.
    PubMed    
    Abstract available

  21. BOCCHIO F, Mancabelli L, Milani C, Lugli GA, et al
    Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases.
    Microbiome Res Rep. 2024;4:2.
    PubMed    
    Abstract available

  22. ZHONG Y, Bai H, Zhang Y, Yang X, et al
    Association of rotating shift work with incident irritable bowel syndrome: a large population-based prospective cohort study.
    Front Public Health. 2025;13:1541122.
    PubMed    
    Abstract available

  23. CHOI Y, Youn YH, Kang SJ, Shin JE, et al
    2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2025;31:133-169.
    PubMed    
    Abstract available

  24. LUO J, To WLW, Xu Q, Zhang J, et al
    Clinical practice guidelines for the diagnosis of constipation-predominant irritable bowel syndrome and functional constipation in adults: a scoping review.
    BMC Gastroenterol. 2025;25:234.
    PubMed    
    Abstract available

  25. MUJAGIC Z
    Gut Feelings Matter: The Unresolved Questions of Irritable Bowel Syndrome-Like Symptoms in Inflammatory Bowel Disease in Remission.
    Inflamm Bowel Dis. 2025 Apr 9:izaf066. doi: 10.1093.
    PubMed    


  26. ANDREWS MB, Adler DG
    Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database.
    Expert Opin Drug Saf. 2025 Apr 9:1-7. doi: 10.1080/14740338.2025.2490841.
    PubMed    
    Abstract available

  27. MELCHIOR C, Hreinsson JP, Tack J, Keller J, et al
    Disorders of the gut-brain interaction among European people with obesity: Prevalence and burden of compatible symptoms.
    United European Gastroenterol J. 2025 Apr 7. doi: 10.1002/ueg2.12700.
    PubMed    
    Abstract available

  28. WANG Q, Zhao L, Liu J, Chen L, et al
    Meta analysis of clinical efficacy of acupoint application in the treatment of irritable bowel syndrome.
    Afr Health Sci. 2024;24:351-361.
    PubMed    
    Abstract available

  29. GAO Z, Mei Z, Zhang Y, Lv S, et al
    Exploring the Genetic Link between Irritable Bowel Syndrome and Polycystic Ovary Syndrome: Bidirectional Mendelian Randomization and Machine Learning Approaches.
    Endocr Metab Immune Disord Drug Targets. 2025.
    PubMed    
    Abstract available

  30. SINOPOULOU V, Groen J, Gordon M, Mougey E, et al
    Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain-not otherwise specified, and abdominal migraine in children: a systematic review and network meta-analysis.
    Lancet Child Adolesc Health. 2025;9:315-324.
    PubMed    
    Abstract available

  31. GUILMINEAU C, Tremblay-Franco M, Vialaneix N, Servien R, et al
    Phoenics: a novel statistical approach for longitudinal metabolomic pathway analysis.
    BMC Bioinformatics. 2025;26:105.
    PubMed    
    Abstract available

  32. VON MUHLENBROCK C, Landskron G, Madrid AM
    Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study.
    Rev Gastroenterol Mex (Engl Ed). 2025 Apr 15:S2255-534X(25)00002.
    PubMed    
    Abstract available

  33. GONCHARENKO AI, Gorbovskoi FV, Kargina EA, Kondrat'eva NM, et al
    [Therapy for irritable bowel syndrome: focus on butylbromide hyoscine. A review].
    Ter Arkh. 2025;97:176-184.
    PubMed    
    Abstract available

  34. SEETHARAMAN J, Poddar U, Srivastava A, Sarma MS, et al
    Spectrum of Functional Abdominal Pain Disorders in Children and Their Clinical, Social Characteristics: A Cross-Sectional Study.
    JGH Open. 2025;9:e70162.
    PubMed    
    Abstract available

  35. GOELEN N, Scheepers J, Carbone F, Holvoet L, et al
    The Waiting Room Questionnaire, a Patient-Reported Outcome Instrument Including Pictograms for Facilitating the Diagnosis of Functional Gastrointestinal Disorders.
    Neurogastroenterol Motil. 2025 Apr 14:e70019. doi: 10.1111/nmo.70019.
    PubMed    
    Abstract available

  36. FANG Y, Zhu J, Wang Z, Li K, et al
    [Mechanism research progress on acupuncture-moxibustion therapy for functional gastrointestinal disorders: review and prospects].
    Zhongguo Zhen Jiu. 2025;45:551-558.
    PubMed    
    Abstract available

  37. TIAN Y, Zi J, Hu Y, Zeng Y, et al
    Shared and Unique Genetic Links between Neuroticism and Gastrointestinal Tract Diseases.
    Depress Anxiety. 2024;2024:5515448.
    PubMed    
    Abstract available

  38. WANG J, Meng N, Chen K, Huang X, et al
    The Relationship Between Depressive Symptoms and Functional Gastrointestinal Disorders (FGIDs): The Chain Mediating Effect of Sleep Disorders and Somatic Symptom.
    Depress Anxiety. 2024;2024:5586123.
    PubMed    
    Abstract available

  39. WANG L, Zhang Y, Ran Y, Li L, et al
    Association between AHR in EGCs and IBS-D patients: the indole pathway of tryptophan metabolism.
    Front Nutr. 2025;12:1566595.
    PubMed    
    Abstract available

  40. HYDER N, Raza ML
    Stress and the gut microbiota-brain axis.
    Prog Brain Res. 2025;291:175-203.
    PubMed    
    Abstract available

  41. THAKUR R, Kaur S
    Use of postbiotics and parabiotics from lactobacilli in the treatment of infectious diarrhea.
    Microb Pathog. 2025;204:107580.
    PubMed    
    Abstract available

  42. CHEN W, Li T, Lin Y, Chen Z, et al
    Patchouli alcohol restores gut homeostasis in irritable bowel syndrome with diarrhea through myosin Va-mediated neurotransmitter regulation.
    Phytomedicine. 2025;141:156681.
    PubMed    
    Abstract available

  43. KEUKENS A, Veth VB, van de Kar MMA, Bongers MY, et al
    Effects of a low-FODMAP diet on patients with endometriosis, a prospective cohort study.
    BMC Womens Health. 2025;25:174.
    PubMed    
    Abstract available

  44. LIEBANA-CASTILLO AR, Redondo-Cuevas L, Nicolas A, Martin-Carbonell V, et al
    Should We Treat SIBO Patients? Impact on Quality of Life and Response to Comprehensive Treatment: A Real-World Clinical Practice Study.
    Nutrients. 2025;17:1251.
    PubMed    
    Abstract available

  45. NASS BYS, Dibbets P, Markus CR
    Mediating Role of Negative Affectivity in the Association Between Lifetime Trauma and Gastrointestinal Symptoms.
    Healthcare (Basel). 2025;13:755.
    PubMed    
    Abstract available

  46. LINSALATA M, Prospero L, Ignazzi A, Riezzo G, et al
    Depression in Diarrhea-Predominant IBS Patients: Exploring the Link Between Gut Barrier Dysfunction and Erythrocyte Polyunsaturated Fatty Acid Levels.
    J Clin Med. 2025;14:2483.
    PubMed    
    Abstract available

  47. TILL SR, Whitmore G, As-Sanie S, Matallana L, et al
    Cannabidiol use and perceptions of effectiveness in women with chronic pelvic pain.
    J Obstet Gynaecol Can. 2025 Apr 9:102839. doi: 10.1016/j.jogc.2025.102839.
    PubMed    
    Abstract available

  48. KIM DH, Song HY, Nam K
    [Pharmacologic Treatment of Irritable Bowel Syndrome with Predominant Constipation].
    Korean J Gastroenterol. 2025;85:110-116.
    PubMed    
    Abstract available

  49. KIM MC, Park Y, Lee HS
    [Treatment of Irritable Bowel Syndrome with Predominant Diarrhea].
    Korean J Gastroenterol. 2025;85:105-109.
    PubMed    
    Abstract available

  50. KANG SJ
    [Dietary Therapy in Irritable Bowel Syndrome].
    Korean J Gastroenterol. 2025;85:97-104.
    PubMed    
    Abstract available

  51. HELM ED, Nguyen C, Rotholz S, Guntupalli SR, et al
    Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire.
    Gynecol Oncol Rep. 2025;59:101739.
    PubMed    
    Abstract available

  52. SANDBERG-JANZON A, Karling P
    Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study.
    Neurogastroenterol Motil. 2025 Apr 24:e70063. doi: 10.1111/nmo.70063.
    PubMed    
    Abstract available

  53. ANNAHAZI A, Bauer R, Efferth T, Khayyal MT, et al
    A Review of the Mechanisms of Action of the Herbal Medicine, STW 5-II, Underlying Its Efficacy in Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2025 Apr 24:e70047. doi: 10.1111/nmo.70047.
    PubMed    
    Abstract available

  54. TSUBOTA M, Sasaki K, Shin E, Okamura Y, et al
    HMGB1 derived from macrophages and enteric glial cells contributes to the butyrate-induced colonic hypersensitivity in mice.
    Eur J Pharmacol. 2025 Apr 22:177660. doi: 10.1016/j.ejphar.2025.177660.
    PubMed    
    Abstract available

  55. SINGH P, Dean G, Iram S, Peng W, et al
    Efficacy of Mediterranean Diet vs. Low-FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial.
    Neurogastroenterol Motil. 2025 Apr 24:e70060. doi: 10.1111/nmo.70060.
    PubMed    
    Abstract available

  56. KINSINGER S, Palsson O
    Survey of Current Practices and Experiences of Clinicians Treating Irritable Bowel Syndrome (IBS) With Cognitive Behavioral Therapy and/or Gut-Directed Hypnosis.
    Neurogastroenterol Motil. 2025 Apr 24:e70058. doi: 10.1111/nmo.70058.
    PubMed    
    Abstract available

  57. FARZANEGAN M, Azizi A, Fard SS, Sadeghi A, et al
    Effectiveness of a bioenergy economy program versus mindfulness-based cognitive therapy on the severity and psychological symptoms of irritable bowel syndrome.
    J Educ Health Promot. 2025;14:107.
    PubMed    
    Abstract available

  58. ROMETSCH C, Martin A, Cosci F
    Predictors of Treatment Success of Psychotherapy in Functional Disorders: A Systematic Review of the Literature.
    Clin Psychol Psychother. 2025;32:e70075.
    PubMed    
    Abstract available

  59. LU YL, Huang C, Huang SY, Li T, et al
    The mechanism of patchouli alcohol in treating IBS-D based on BMP-Smad pathway.
    Biomed Pharmacother. 2025;187:118050.
    PubMed    
    Abstract available

  60. BAKHSHAIE J, Smit T, Bradford A, Lackner JM, et al
    Gastrointestinal-specific anxiety as a transdiagnostic mechanism involved in persons with irritable bowel syndrome who smoke.
    J Health Psychol. 2025 Apr 23:13591053251333950. doi: 10.1177/13591053251333950.
    PubMed    
    Abstract available

  61. JAFARI NASAB S, Hajihashemi P, Feizi A, Shahoon H, et al
    Effects of Spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity, malondialdehyde and zonulin in constipation-predominant irritable bowel syndrome: protocol for a randomised, double-blinded, p
    BMJ Open. 2025;15:e086521.
    PubMed    
    Abstract available

  62. NASAB SJ, Feizi A, Hajihashemi P, Entezari MH, et al
    Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, antioxidant and inflammatory markers, quality of life and disease severity in patients with constipated-predominant irritable bowel syndrome: a randomized double?
    Nutr J. 2025;24:64.
    PubMed    
    Abstract available

  63. SHIN A
    Expanding the menu of dietary therapies in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00070.
    PubMed    


  64. KHASAWNEH M, Mokhtare M, Moayyedi P, Black CJ, et al
    Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00051.
    PubMed    
    Abstract available

  65. CUFFE MS, Staudacher HM, Aziz I, Adame EC, et al
    Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00054.
    PubMed    
    Abstract available

  66. BENARD MV, de Bruijn CMA, Matamoros S, Wentink-Bonnema EMS, et al
    Transient colonization with Blastocystis spp. after transmission via fecal microbiota transplantation.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 21. doi: 10.1007/s10096-025-05124.
    PubMed    
    Abstract available

  67. MEI C, Han L, Xue H
    Exploring the Comorbidity Mechanism among Functional Diarrhea, Irritable Bowel Syndrome with Predominant Diarrhea, and Functional Dyspepsia through the Gut-brain Axis and the Pharmacological Mechanisms of Shen-Ling-Bai-Zhu-San Therapy.
    Comb Chem High Throughput Screen. 2025.
    PubMed    
    Abstract available

  68. DU Z, Zhao C, Li J, Shen Y, et al
    Ginsenosides and gut microbiota: differential effects on healthy individuals and irritable bowel syndrome subtypes.
    PeerJ. 2025;13:e19223.
    PubMed    
    Abstract available

  69. SOUFAN F, Ghosson A, Jaber R, Ghandour A, et al
    The Gut-Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention-A Narrative Review.
    Health Sci Rep. 2025;8:e70660.
    PubMed    
    Abstract available

  70. WEI X, Jia X, Su X
    Evidence-Based Bibliometric Analysis of Acupuncture in Functional Dyspepsia: Clinical Efficacy and Research Trends.
    J Multidiscip Healthc. 2025;18:2141-2153.
    PubMed    
    Abstract available

  71. KIM TH, Son Y, Park J, Kim S, et al
    Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study.
    J Med Virol. 2025;97:e70345.
    PubMed    


  72. WANG XJ, Philpot L, Ebbert J, Dilmaghani S, et al
    Digital Therapeutic Combining Hypnosis and Diaphragmatic Breathing Intervention for Functional Abdominal Bloating: A Feasibility Study.
    Clin Transl Gastroenterol. 2025;16:e00811.
    PubMed    
    Abstract available

  73. KHUNSRIRAKSAKUL C, Ziegler O, Liu D, Kulaylat AS, et al
    The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population-Based Study.
    Aliment Pharmacol Ther. 2025 Apr 11. doi: 10.1111/apt.70147.
    PubMed    
    Abstract available

  74. CAMILLERI M
    When and What to Test for Diarrhea: Focus on Stool Testing.
    Am J Gastroenterol. 2025;120:778-784.
    PubMed    
    Abstract available

  75. WALLEN H, Ljotsson B, Lindfors P, Forsell E, et al
    Internet-Delivered Exposure-Based Cognitive Behavior Therapy for Irritable Bowel Syndrome: A Clinical Effectiveness Study.
    Am J Gastroenterol. 2025;120:856-863.
    PubMed    
    Abstract available

  76. QUIGLEY EMM
    Dyspepsia-Is the Stomach Half Empty?
    Dig Dis Sci. 2025 Apr 18. doi: 10.1007/s10620-025-09038.
    PubMed    


  77. YAMANE T, Masaoka T, Ishii C, Masuoka H, et al
    Factors contributing to the efficacy of fecal microbiota transplantation for diarrhea-dominant functional bowel disorders.
    Digestion. 2025 Apr 10:1-22. doi: 10.1159/000545183.
    PubMed    
    Abstract available

  78. GOYAL O, Goyal P, Goyal MK, Jain K, et al
    Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center- A cross-sectional study.
    Indian J Gastroenterol. 2025 Apr 15. doi: 10.1007/s12664-025-01770.
    PubMed    
    Abstract available

  79. JEON SH, Kim M, Choi S, Son S, et al
    Study protocol for a prospective, investigator-initiated clinical trial on the vascular effects of acupuncture in the abdomen and lower limbs for patients with diarrhea-predominant irritable bowel syndrome.
    Int J Colorectal Dis. 2025;40:103.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;